Browsing Category

Top Industry News

7388 posts

AbbVie Investing $195 M in US-Based API Mfg Expansion 
By

By
AbbVie has announced a $195-million investment in its North Chicago, Illinois, manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.   This expansion is part of AbbVie’s…

BioNTech in $740-M Settlement in US with CureVac, GSK over COVID mRNA Vaccine 
By

By
Pfizer and BioNTech, a Mainz, Germany-based bio/pharmaceutical company, have entered an agreement with GSK and CureVac, a Tubingen, Germany-based clinical-stage bio/pharmaceutical company specializing in mRNA cancer immunotherapies and vaccines, to…

FDA Launches Pre-Check Program to Boost US-Based Drug Mfg 
By

By
The US Food and Drug Administration (FDA) has announced FDA PreCheck, a new program the agency says is designed to strengthen the domestic pharmaceutical supply chain by increasing regulatory predictability…

Bayer, Kumquat Biosciences in $1.3-Bn Cancer Drug Pact 
By

By
Bayer and Kumquat Biosciences, a San Diego, California-based clinical-stage biotech company, have entered into an exclusive global license and collaboration to develop and commercialize a cancer drug by Kumquat, a…

Supplier News: Pace Life Sciences, Sartorius, ProBio, Sanner & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Pace Life Sciences, Sartorius, Acrinova, ProBio, Sanner, Nanotein Technologies.   Biologics Manufacturing * ProBio Launches AAV Mfg Services * Sartorius, Nanotein Technologies Partner for Cell…

Moderna To Cut Workforce by 10% 
By

By
Moderna, a Cambridge, Massachusetts-based vaccine manufacturer and specialist in mRNA technology-based products, has announced an organizational restructuring that will reduce its global workforce by approximately 10%. The company anticipates a…

Vaccine Maker Bavarian Nordic Awaits $3-Bn Purchase Offer by PE Firms
By

By
Bavarian Nordic, a Hellerup, Denmark-based vaccine company, has entered into an announcement agreement for an all-cash recommended purchase offer of approximately DKK 19 billion ($2.91 billion) with a private equity…

GSK, Hengrui Pharma in $12.5-Bn Multi-Drug Pact 
By

By
GSK has entered into agreements with Hengrui Pharma, a Lianyungang, China-based bio/pharmaceutical company, to develop up to 12 medicines across several therapeutic areas (respiratory, immunology & inflammation, and oncology) in…

Supplier News: Esteve CDMO, Axplora, Bora, Garonit Pharmaceuticals & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Garonit Pharmaceuticals, Axplora, Bora Pharmaceuticals, Esteve CDMO, Asahi Kasei, and Solvias USA.   Chemicals/Chemical API Manufacturing * Ofichem Acquires Early-Phase Drug-Substance Site from Meribel…

M&A News: Sanofi, Aurobindo, Lilly & More 
By

By
The latest news on mergers and acquisitions featuring Sanofi/Vigil Neuroscience, Aurobindo/Lannett and Eli Lilly and Company/Verve Therapeutics. Highlights below.  * Sanofi Acquires Vigil Neuroscience for $470 M * Aurobindo To Acquire…